过去一年中添加的文章，按日期排序
Efficacy from the phase 1 study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with head and neck squamous cell carcinoma.
22 天前 - … : The study evaluated the safety, PK, and preliminary … Three out of 5 HNSCC patients
previously treated with a taxane … A phase 2 study of FID with cetuximab in pts with HNSCC …
previously treated with a taxane … A phase 2 study of FID with cetuximab in pts with HNSCC …
Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M …
D Ji, Y Sang, X Liu, Y Guo, Y Yang, G Chen, S Dong… - 2024 - ascopubs.org
22 天前 - … as first-line treatment in R/M HNSCC (NCT05673577). We report the results of
stage 1 of this study. Methods: Eligible … Out of 21, 13 patients completed planned cycles of …
stage 1 of this study. Methods: Eligible … Out of 21, 13 patients completed planned cycles of …
Early activity and biomarker evaluation of NT219 in combination with cetuximab in a Phase 1/2 study of recurrent/metastatic squamous cell carcinoma of the head and …
AJ Rosenberg, S Kato, D Johnson, A Popovtzer… - Cancer Research, 2024 - AACR
90 天前 - 5181: Early activity and biomarker evaluation of NT219 in combination with cetuximab
in a Phase 1/2 study of recurrent/metastatic squamous cell carcinoma of the head and …
in a Phase 1/2 study of recurrent/metastatic squamous cell carcinoma of the head and …
[HTML][HTML] Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a …
J Guigay, C Ortholan, D Vansteene… - The Lancet Healthy …, 2024 - thelancet.com
111 天前 - … 151 failures expected out of 164 patients were required to … patients with head and
neck cancer are included in clinical trials but … Due to the early termination of the trial after the …
neck cancer are included in clinical trials but … Due to the early termination of the trial after the …
[HTML][HTML] Comuna Casa GrandeVALLE DE PUNILLA| CÓRDOBA
J Carrier - casagrande.gov.ar
148 天前 - … research using radionuclide-labeled Cetuximab in with … , possible early and late
unwanted effects, alternative treatment … Clinical Trials and Studies With Results Multiple studies …
unwanted effects, alternative treatment … Clinical Trials and Studies With Results Multiple studies …